OTCMKTS:RDSMY
Delisted
Royal D S M Nv ADR Stock News
$33.77
+0 (+0%)
At Close: Feb 10, 2023
Royal DSM: Quality At A Price
12:25am, Tuesday, 23'rd Aug 2022
Royal DSM has proven its resilience through the near-term macro challenges. Its upcoming merger with Firmenich also appears promising and could deliver upside going forward.
Koninklijke DSM N.V. (RDSMY) CEO Geraldine Matchett on Q2 2022 Results - Earnings Call Transcript
01:27pm, Tuesday, 02'nd Aug 2022
Koninklijke DSM N.V. (OTCQX:RDSMY) Q2 2022 Results Conference Call August 2, 2022 8:00 AM ET Company Participants Dave Huizing - Vice President of Investor Relations Geraldine Matchett - Chief Executi
Health and biotech firm says it has enjoyed resilient demand as health kick is here to stay
08:19am, Tuesday, 02'nd Aug 2022
Dimitri de Vreeze, co-CEO of DSM, discusses his company's earnings and explains why demand has remained strong.
UNVR or RDSMY: Which Is the Better Value Stock Right Now?
01:12pm, Monday, 04'th Jul 2022
UNVR vs. RDSMY: Which Stock Is the Better Value Option?
'A merger of equals': Firmenich CEO Ghostine on DSM deal
08:17am, Tuesday, 31'st May 2022
Firmenich CEO Gilbert Ghostine describes the company's deal with sector peer DSM as a "merger of equals."
UNVR vs. RDSMY: Which Stock Should Value Investors Buy Now?
12:48pm, Monday, 30'th May 2022
UNVR vs. RDSMY: Which Stock Is the Better Value Option?
DOW or RDSMY: Which Is the Better Value Stock Right Now?
12:48pm, Friday, 06'th May 2022
DOW vs. RDSMY: Which Stock Is the Better Value Option?
DOW or RDSMY: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 20'th Apr 2022
DOW vs. RDSMY: Which Stock Is the Better Value Option?
DOW vs. RDSMY: Which Stock Is the Better Value Option?
12:48pm, Monday, 04'th Apr 2022
DOW vs. RDSMY: Which Stock Is the Better Value Option?
By 2028, Global Demand for Green Chemicals Market Will Surpass $16684.27 Million at 9.10% CAGR Growth | Says Vantage Market Research
11:48am, Wednesday, 16'th Mar 2022 Benzinga
WASHINGTON, March 16, 2022 (GLOBE NEWSWIRE) -- According to a new market research report " Green Chemicals Market Size, Share & Trends Analysis Report by Product (Bioalcohols, Biopolymers, Biosolvents, Organic Acids), by Applications (Food & Beverages, Personal Care, Packaging, Automotive), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)", published by Vantage Market Research, the global post COVID-19 market size of the Green Chemicals Market is expected to grow from USD 9,893.70 Million in 2021 to USD 16684.27 Million by 2028 at a CAGR of 9.10% during the forecast period. Please Check Out Our Free Sample Reports and Make a More Informed Decision: Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/green-chemicals-market-1347/request-sample (Sample reports are a great way to test our in-depth reports or study before you make a purchase) The newly updated, 140+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.
5 Great Green Stocks Making a Direct Impact
11:50am, Friday, 25'th Feb 2022
It's the end of business as usual. To save the planet, consumers, companies and governments all over the world are stepping up their sustainability game, or at least pledging to do so.
Surgical Display Market to Reach USD 655.1 million by 2022-2028 | Opportunities, Challenges, Regions, Types, Applications, Key Players
06:18am, Thursday, 17'th Feb 2022 Benzinga
Pune, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Global Surgical Display Market report delivers a complete overview of key components like drivers, limitations, historic and current trends, technical development, and future growth. Research report contains company analysis, size, share, revenue and sales of the company, current advancements. Surgical Display market analysis also focuses on the global key top industry players in the market, with details such as company profiles, capacity, production, price, cost, revenue. According to a study by Researcher, is anticipated to reach at USD 655.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 0.9% from 2021 to 2028. Get a Sample Copy of the Report at - https://www.absolutereports.com/enquiry/request-sample/20198842 The top players are concentrating mostly on technical developments in order to increase efficiency. The long-term growth patterns for this market can be taken by continuing the current development progresses and financial strength to participate in the best strategies.
Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript
07:23pm, Tuesday, 15'th Feb 2022 Seeking AlphaKoninklijke DSM N.V. Non-GAAP EPS of €4.92, revenue of €9.2B
02:51pm, Tuesday, 15'th Feb 2022 Seeking Alpha
Koninklijke DSM N.V. press release (RDSMY): FY Non-GAAP EPS of €4.92.Revenue of €9.2B (+13.4% Y/Y).
Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript
02:23pm, Tuesday, 15'th Feb 2022
Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript